PTHS vs IMA
Comparison between Channel Therapeutics Corporation (PTHS, Company) and Ikena Oncology Inc (IMA, Company).
Both PTHS and IMA are from the Healthcare sector.
PTHS vs IMA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
PTHS
$97M
IMA
$97M
Max Drawdown
Winner
PTHS
88.73%
IMA
98.82%
Sharpe Ratio
Winner
PTHS
0.85
IMA
-0.92
5Y Beta
PTHS
1.07
Winner
IMA
0.63
Industry
PTHS
Biotechnology
IMA
Biotechnology
P/E Ratio
PTHS
-0.74
Winner
IMA
-0.94
PEG Ratio
PTHS
-0.00
Winner
IMA
-0.04
Debt to Equity
PTHS
0.00%
IMA
0.00%
Free Cash Flow Yield
Winner
PTHS
-36.31%
IMA
-59.64%
P/S Ratio
PTHS
3.63
IMA
N/A
P/B Ratio
PTHS
2.87
IMA
N/A
PTHS vs IMA - Historical Returns
Returns include dividend reinvestment.
1M
Winner
PTHS
+9.03%
IMA
-3.93%
3M
Winner
PTHS
+10.03%
IMA
+1.73%
6M
Winner
PTHS
+39.07%
IMA
-15.05%
1Y
Winner
PTHS
+57.43%
IMA
-58.66%
5Y(CAGR)
PTHS
N/A
IMA
-46.13%
Max(CAGR)
Winner
PTHS
-18.76%
IMA
-54.01%
PTHS vs IMA - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | PTHS | IMA |
|---|---|---|
| 2026 | -2.82% | -13.17% |
| 2025 | +328.54% | -65.15% |
| 2024 | -86.65% | -17.59% |
| 2023 | N/A | -24.81% |
| 2022 | N/A | -80.72% |
| 2021 | N/A | -60.81% |
PTHS vs IMA Drawdown Comparison
The maximum drawdown for PTHS was -88.73%, occurring on Nov 19, 2024. This drawdown has not yet recovered.
The maximum drawdown for IMA was -98.82%, occurring on Apr 6, 2026. This drawdown has not yet recovered.
The current PTHS drawdown is -40.37%. The current IMA drawdown is -98.47%.
| Rank | PTHS | IMA |
|---|---|---|
| #1 | -88.73% Feb 16, 2024 - Nov 19, 2024 | -98.82% Mar 26, 2021 - Apr 6, 2026 |
Correlation
Correlation between PTHS and IMA is -0.71 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
-0.71
-101
Select Stocks to Compare
Popular: PTHS vs SPYIMA vs SPY
More Comparisons
Compare with similar stocks